OptiGen now offers the CL test for Neuronal
Ceroid Lipofuscinosis in Border Collies.
NCL, sometimes called canine
ceroid lipofuscinosis in dogs, is a storage disease; toxins that the body normally would eliminate as waste build up in certain tissues.
The Neuronal
ceroid lipofuscinosis (NCLs) are a group of inherited neurodegenerative diseases characterized by accumulation of autofluorescent cytoplasmic antibodies within cells of the nervous system.
Neuronal Canine
Ceroid Lipofuscinosis (CCL).
P. Gupta, et al., Disruption of PPT1 or PPT2 causes neuronal
ceroid lipofuscinosis in knockout mice, Proc.
However, the studies proved that the later onset of retina changes is probably caused by Neuronal
Ceroid Lipofuscinosis (NCL) that means completely different genetic disease (Lionel F. Rubin et al. 1995).
Border Collie breeders are usually very proactive in testing for the genetic diseases Collie Eye Anomaly / Choroidal Hypoplasia, Neuronal
Ceroid Lipofuscinosis and Trapped Neutrophil Syndrome, but you should check with your breeder before buying a Border Collie on the status of their dogs for genetic diseases.
July 25, 2005 CL (NCL - Neuronal
Ceroid Lipofuscinosis) Test for Border Collies The genetic test for Neuronal
Ceroid Lipofuscinosis in Border Collies is offered by OptiGen as of July 25, 2005.
In 2005 a nonsense mutation (c. 619C > T) in exon 4 in the canine CLN5 gene was reported to be linked to a specific form of Neuronal
Ceroid Lipofuscinosis found in Border Collies.
There are many forms of Neuronal
Ceroid Lipofuscinosis (NCL) result in progressive degeneration of the central nervous system.
The genetic test verifies the presence of the Neuronal
Ceroid Lipofuscinosis mutation and presents results as one of the following:
Neuronal
ceroid lipofuscinosis (NCL) is a rare but serious disease that is limited to show Border Collies.
For three years now we have been working on human cell models of rare neurodegenerative diseases with special emphasis on neuroacanthocytosis, neuronal
ceroid lipofuscinosis as well as motor neuron degeneration (using iPS cells).
Common pathobiochemical hallmarks of progranulin - associated frontotemporal lobar degeneration and neuronal
ceroid lipofuscinosis.
The two forms of neurodegeneration are frontotemporal dementia (FTD) and neuronal
ceroid lipofuscinosis (NCL).
He has been researching juvenile neuronal
ceroid lipofuscinosis (Batten disease) since 1997.
Human iPSC models of neuronal
ceroid lipofuscinosis capture distinct effects of TPP1 and CLN3 mutations on the endocytic pathway.
The children all have late infantile neuronal
ceroid lipofuscinosis (LINCL), a form of the neurodegenerative disorder Batten disease.
In a mouse model of late infantile neuronal
ceroid lipofuscinosis (NCL), a pediatric neurological disease, the researchers described retinal degenerative changes that mimic the characteristic pathology of age - related macular degeneration (AMD).
The drug candidate is intended for the treatment of subjects with neuronal
ceroid lipofuscinosis, aka Batten Disease, a fatal lysosomal storage disease that primarily affects the nervous system in children.